Picture of Core Laboratories logo

CLB Core Laboratories News Story

0.000.00%
us flag iconLast trade - 00:00
IndustrialsAdventurousMid CapNeutral

Oilfield reservoir manager Core Labs Q3 revenue beats estimates on strong demand

Overview

Core Labs Q3 revenue of $134.5 mln beats analyst expectations, per LSEG data

Company repurchased 462,248 shares, valued at $5.0 mln

Core Labs completed acquisition of Solintec, expanding Brazilian operations

Outlook

Core Labs projects Q4 revenue between $132 mln and $136 mln

Company expects Q4 2025 EPS of $0.18 to $0.22

Reservoir Description Q4 revenue projected at $88 mln to $90 mln

Result Drivers

GLOBAL DEMAND - Sequential revenue growth driven by global demand for proprietary services and products

ASIA-PACIFIC PROGRAMS - Committed exploration and development programs in Asia-Pacific region contributed to results

SOLINTEC ACQUISITION - Acquisition of Solintec expanded Brazilian operations and capabilities

Key Details

MetricBeat/MissActualConsensus Estimate
Q3 RevenueBeat$134.50 mln$130.90 mln (3 Analysts)
Q3 EPS$0.30
Analyst Coverage The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and 1 "sell" or "strong sell" The average consensus recommendation for the business support services peer group is "buy." Wall Street's median 12-month price target for Core Laboratories Inc is $14.00, about 14% above its October 21 closing price of $12.04 The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 15 three months ago Press Release: ID:nPnb5F1n0a For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Core Laboratories

See all news